A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus

Condition:   Systemic Lupus Erythematosus Interventions:   Drug: RO7507062;   Drug: Tocilizumab Sponsor:   Hoffmann-La Roche Not yet recruiting

Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials